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Abstract 
 
Background:  Genital herpes is a common sexually transmitted disease in many developed and developing 
countries mostly caused by Herpes simplex virus type 2 (HSV-2). This study determines the prevalence of HSV-2 
infection between two groups of women with high and low risk behaviors.  
 
Methods: In this seroepidemiologic study, 362 women attending obstetrics and gynecology clinics as low risk 
group and 156 prisoners and drop in center resident women in Tehran as high risk group were enrolled. HSV 
infection was identified by serologic tests on blood samples.  
 
Results: The prevalence of IgG antibody in high risk group was significantly more than low risk women (26.3% 
vs. 2.5%). The prevalence of IgM antibody in high risk group was less than low risk group (3.8% vs. 7.1%) but 
the difference was not statistically significant. In high risk group, there was significant association between posi-
tive IgG and anal/oral sex, use of condom, smoking and drug addiction as well as genital pain, burning, itching, 
ulcer, dysuria, and history of genital infection. In low risk group, association between positive IgM and IgG test 
results and risky behaviors were not significant. There was significant association between IgM and genital itch-
ing, rash, and ulcer. 
 
Conclusion: Relatively high seroprevalence of anti-HSV-2 IgG and high frequency of genital Herpes among high 
risk women necessitates regular screening and safe sex education programs. Moreover, risk of acute infection in 
this group should not be ignored and its distribution in Iranian population should be alarmingly concerned. 
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Introduction 
 
Genital Herpes is a common sexually transmitted dis-
ease (STD) in many developed and developing coun-
tries. It is caused by the Herpes simplex virus type 1 
(HSV-1) or type 2 (HSV-2) but the most genital Her-
pes is caused by HSV-2. After initial infection, the 
virus can reside as life-long virus and remains latent 
until opportunity for recurrence, thus genital Herpes 
is a recurrent, incurable viral disease.
1 Periodic recur-
rent infections are associated with viral shedding at 
the site of primary infection.
2 The primary and subse-
quent recurrent infections are affected by factors such 
as surgical operation, stress and immune suppres-
sion.
3 The majority of both primary and recurrent in-
fections are asymptomatic diseases
4 however, in 
symptomatic cases lesions are very painful
5 and obvi-
ously affect the quality of life in patients.
6,7 Because 
of asymptomatic nature of disease, Herpes simplex 
viruses will be easily spread in population and is a 
suitable marker to evaluate the sexual behaviors.
5 
Genital  Herpes is associated with psychological   
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morbidity,
8 so the social stigma attached to this dis-
ease has been investigated and its impact on patients 
has been emphasized in many studies.
9,10 Nowadays, 
the synergistic interaction between HSV-2 and trans-
mission of HIV is a risk factor associated with a two- 
to three-fold increased risk of HIV acquisition.
11-14 
Estimating the global burden of diseases is consid-
erable to recognize the scale of an epidemic, encour-
age governments and organizations for investing in 
disease control and proper distribution of resources to 
those most affected.
15  The prevalence of HSV-2 in 
different countries was collected by systematic re-
view study in 2002,
16 then in 2005,
17 and finally the 
universal genital Herpes outbreak by age and gender 
has been reported in 2008.
18 Although the prevalence 
in the Middle East and North Africa has been report-
ed lower than other regions,
19 but the statistical data 
in Iran are not presented in these studies which re-
quires a prevalence study in our country.  
In attention to the prevalence of infection in de-
veloping countries, HSV-2 transmission through sex-
ual contacts, asymptomatic cases of disease which 
caused rapid infection spread, incurable and recurrent 
nature of HSV-2 illness, necessitate genital Herpes 
simplex screening programs. Therefore, this study 
aimed to compare the prevalence of HSV-2 infection 
as the main cause of genital Herpes  among two 
groups of women with high risk behaviors and wom-
en from normal population attending obstetrics and 
gynecology clinics of Tehran, Capital of Iran. 
 
 
Materials and Methods 
 
Three hundreds and sixty two women aged 15-49 
years (reproductive age) attending obstetrics and gy-
necology clinics of social security insurance in differ-
ent districts of Tehran as low risk group and 156 pris-
oner women and women attending drop in center 
(DIC) in Tehran as high risk group, were enrolled in 
this cross sectional study after signing a written in-
formed consent, which was approved by Avicenna 
Medical Ethics Research Committee.  
Samples were collected using consecutive method 
in a laboratory by a person who was trained on inter-
viewing techniques and sample collection. About 3-5 
ml blood sample was taken from each participant and 
with completed questionnaires and informed consents 
transferred to Avicenna Research Institute daily. 
Blood samples were centrifuged at 3000 RPM for 
5-10 min to separate the blood cell mass from the   
serum. The sera were aliquoted into 0.5 ml and 1.5 ml 
vials and frozen at -20◦ C until use. HSV-2 antibodies 
were tested with Enzyme-Linked Immunosorbent As-
say (ELISA) using Anti HSV-2 (IgG/IgM) ELISA Kit 
(Euro immune Deutschland, Germany). The serum 
samples were diluted 1:101 with sample buffer and 
the ELISA procedure was performed according to 
manufacturer's instruction.  
According to the kit manual, the values less than 
0.8 were considered as negative while equal and more 
than 1.1 were positive, the borderline ranged between 
0.8 to 1.1 and the cutoff point was determined as 1. 
The kit could detect at least 0.05 anti-HSV-2 with 
100% specificity.  
Test results and questionnaire data were analyzed 
using SPSS package (hicago, IL, USA). Independent 
samples T-test evaluated the association between con-
tinuous and dichotomous variables; Chi Square, the 
association between dichotomous variables; Pearson 
correlation coefficient, the correlation between con-
tinuous variables and univariate logistic regression 
evaluated the marital status and educational level be-
tween high risk and low risk groups and being mar-
ried and educational levels were considered as the 
reference group. Multiple logistic regressions evalu-
ated the effect of variables on the dependent variable. 
The dichotomous variable of high and low risk be-
haviors entered the model as a dependent variable. P-
values <0.05 were considered as significant. 
 
 
Results 
 
The prevalence of IgG antibody in women with high 
risk behaviors was significantly more than other 
women (26.3% versus 2.5%; p<0.001). The preva-
lence of IgM antibody in high risk group was less 
than others (3.8% versus 7.1%) but the difference was 
not statistically significant. Also, no significant dif-
ference was found in borderline cases between two 
groups. The data about two groups were shown in 
Table 1 and 2. The mean age of participants in low 
risk group was 32.33±8.41 years and in high risk 
group was 35.19±11.53 (p<0.001) and the mean age 
at first sexual contact in low-risk and high-risk groups 
were 19.83±4.23 and 15.81±4.02 years (p<0.001), 
respectively. 
The number of widowed and divorced women in 
high risk group was significantly more than low risk 
group and in contrast, the number of single and mar-
ried women in low risk group was more than high Asgari et al. 
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risk group (p<0.001). The number of women with 
primary, intermediate and advanced education in low 
risk group was more than high risk group while illit-
erate women in high risk group were more than the 
other group (p<0.001). There was no significant differ-
ence in occupational activities between two groups.  
Among sexual active women with low risk behav-
iors, just one participant expressed that she had anal 
Table 1: Demographic data of women with high-risk and low-risk behaviors in Tehran, 2008 
Demographic data  Women with high-risk 
behaviors 
Women with low-risk 
behaviors 
P value 
Age 35.19±11.53  32.33±8.41  P<0.001
a 
Age at first sexual contact   15.81±4.02  19.83±4.23  P<0.001
 a 
Marital status 
Married 
Single 
Widow 
Divorced 
 
63 (41.2%) 
24 (15.7%) 
44 (28.8%) 
22 (14.4%) 
 
317 (87.8%) 
40 (11.1%) 
3 (0.8%) 
1 (0.3%) 
 
reference
b 
P<0.001 
P<0.001 
P<0.001 
Educational status 
Illiterate 
Elementary 
Intermediate 
Advance 
 
44 (28.2%) 
79 (50.6%) 
31 (19.9%) 
2 (1.3%) 
 
12 (3.3%) 
131 (36.2%) 
165 (45.6%) 
54 (14.9%) 
 
P<0.001
b 
P<0.001 
P=0.033 
reference 
Occupational status 
Employed 
Unemployed 
 
18 (12.2%) 
130 (78.8%) 
 
37 (11.2%) 
292 (88.8%) 
 
P=0.113
 c 
Anal/oral sex  45 (31.8%)  1 (0.3%)  P<0.001
 c 
Being married more than once 
history of polygamous in partner 
31 (20.9%) 
44 (28.7%) 
7 (2.2%) 
18 (5.0%) 
P<0.001
 c 
P<0.001
 c 
Condom use  29 (22.5%)  43 (13.4%)  P<0.001
 c 
Smoking  120 (76.9%)  1 (0.3%)  P<0.001
 c 
Drug abuse  86 (55.1%)  1 (0.3%)  P<0.001
 c 
a Based on independent T test, 
b Based on univariate logistic regression, 
c Based on Chi square 
 
 
Table 2: Infectious data of women with high-risk and low-risk behaviors in Tehran, 2008
Infectious data  Women with high-risk 
behaviors  
No. (%) 
Women with low-risk 
behaviors 
No. (%) 
P value 
Genital pain  47 (30.1)  42 (11.6) 
 P<0.001
a 
Genital burning  51 (32.7)  68 (18.8) 
 P<0.001
a 
Genital itching  49 (31.4)  59 (16.3) 
 P<0.001
a 
Genital skin rashes  18 (11.5)  10 (2.8) 
 P<0.001
a 
Genital ulcer  27 (17.3)  8 (2.2) 
 P<0.001
a 
Dysuria  45 (28.8)  62 (17.1) 
 P<0.001
a 
Genital discharge  60 (38.5)  135 (37.3) 
 P=0.843
a 
History of genital infection  73 (46.8)  197 (54.7) 
 P=0.104
a 
IgG 
Negative 
Positive 
Borderline 
 
112 (71.8) 
41 (26.3) 
3 (1.9) 
 
344 (97.2) 
9 (2.5) 
1 (0.3) 
 
reference
 b 
P<0.001 
P=0.056 
IgM 
Negative 
Positive 
Borderline 
 
143 (91.7) 
6 (3.8) 
7 (4.5) 
 
320 (90.4) 
25 (7.1) 
9 (2.5) 
 
reference
 b 
P=0.341 
P=0.792 
a Based on Chi square, 
b Based on univariate logistic regression  
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or oral sex, while 31.8% of sexual active women in 
high risk group experienced anal/oral sex (p<0.001). 
2.2% of low risk women vs. 20.9% of women in high 
risk group had more than one partner during their life 
(p<0.001) and 28.7% of partners in high risk women 
vs 5.0% of low risk women had polygamous sexual 
history (p<0.001). 13.4% of married women in low 
risk group had used condom as contraceptive method 
during sexual contacts and the others used no or other 
contraceptive methods except than condom, on the 
contrary, 22.5% of sexual active women in high risk 
group had used condom (p<0.001). 76.9% of high 
risk group vs. 0.3% of low risk group were cigarette 
smokers and 55.1% of high risk group vs. 0.3% of 
low risk group were drug abuser (p<0.001). The mul-
tiple logistic regressions showed that being widow or 
divorced (p<0.001), lower mean age in first sex 
(p=0.003), having anal/oral sex (p=0.035), being mar-
ried more than once by woman (p=0.004) and her 
partner (p<0.001), smoking (p<0.001) and drug abuse 
(p<0.001) in high risk group were significantly more 
than low risk group. 
The symptoms of genital infection including geni-
tal pain, burning, itching, genital skin rashes, ulcer 
and dysuria in high risk group were significantly 
more than low risk group (p=0.002), however, no sig-
nificant difference was observed in abnormal vaginal 
discharge and history of  genital infection between 
two groups. 
In order to find the association between high risk 
behaviors and infection, we analyzed each study 
group separately. In high risk group, statistical analy-
sis showed that there was significant association be-
tween positive IgG test results and anal/oral sex 
(p<0.001), condom use (p<0.001), smoking (p=0.025), 
addiction (p<0.001) as well as genital pain (p=0.005), 
burning (p=0.026), itching (p=0.033), ulcer 
(p=0.033), dysuria (p=0.003), and history of genital 
infection (p=0.018). Association between IgM and 
variables were not significant.  
Furthermore, in low risk group, association be-
tween positive IgM and IgG test results and risky be-
haviors were not significant. There was significant 
association between IgM and genital itching 
(p=0.044), rash (p=0.030), and ulcer (p=0.018). 
 
 
Discussion 
 
In this study, the prevalence of HSV-2 IgG in women 
with high risk and low risk behaviors was 26.3% and 
2.5%, respectively. The prevalence of infection 
among general population in developing Asian coun-
tries has been reported 10-30%.
20 A review article has 
reported that the seroepidemiology of infection in 
Asian countries among non-high risk adult ranged 
between 7.9- 29% and among high risk women varied 
between 63-80%. But these data are related to com-
mercial sex workers.
16 The prevalence of infection in 
India and Thailand among patients attending to STI 
clinics and female sex workers has been reported 
26% and 82%, respectively.
21 It seems that the preva-
lence of infection in high risk group in current study 
is lower than other Asian studies which can be caused 
by cultural differences or different definition of high 
risk group in these studies. Also, the seroepidemiolo-
gy of infection in developed countries has been inves-
tigated. A study carried out in the UK has reported that 
the prevalence of anti-HSV-2 antibodies in women 
attending STI clinics was 21%.
22 Considering to the 
type of patients' admission to European clinics, ap-
proximate similarity in HSV-2 infection rate between 
our high risk population and British study is justified.  
In a Switzerland study, the incidence of HSV-2 
IgG in adults aged 35-46 years was 19.3%.
23 The 
studied population was general population who re-
vealed much more prevalence than the current study. 
This disagreement may be caused by moral and reli-
gious commitment, different sample size, distinct and 
accurate diagnostic methods. 
The rate of anti-Herpes simplex virus (HSV) anti-
bodies has been evaluated in 132 Australian prisoner 
women and 58% of them showed positive results
24 
which was much more than our findings and a signif-
icant association was reported between HSV-2 infec-
tion and multi-partner sex. High risk samples in our 
study were taken from women in DIC and prison. A 
group of Persian prisoner women were imprisoned 
because of financial sanctions and most of them were 
married and monogamous. 
The high prevalence of IgG and low prevalence 
rate of IgM in high risk women may possibly be 
caused by sex at young ages (9 years). The mean age 
of women when entering the study was 35.19 years. 
According to the seroconversion time of infection, the 
discrepancy between the prevalence of IgG and IgM 
antibodies was justified.  
Such as others in our study, test results were corre-
lated significantly to smoking, and drug abuse.
25 In 
high risk group that the frequency of positive IgG test 
was higher than low risk group, also the prevalence of 
condom usage was more. Since serologic tests were Asgari et al. 
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positive in all the ways of transmissions, it shows that 
genital Herpes can be transmitted through the orola-
bial.
1 Therefore, there was a statistically significant 
relationship between the result of this test and the 
transmission way of oral/anal. On the other hand, the 
high risk group was mostly multi-partner and their 
IgG positive test which is a sign of infection in the 
past showed a significant relationship with condom 
use, it is likely that infection occurred earlier in un-
protected sex.  
On account of confidence in partner, only 22.5% 
of high risk group used condom as a contraceptive in 
their sexual intercourse but condom has been used in 
low risk group less than prisoners and DIC women. 
Perhaps women with low risk behaviors felt safe in 
sexual contact with their partner. Moreover, no signif-
icant correlation was identified between condom use 
and HSV-2 infection in low risk group. A study per-
formed in Gambia showed that 36% of married wom-
en (at least once) were infected with genital Herpes 
and due to lack of protection in sexual activity; dis-
ease transmission has mostly occurred after mar-
riage.
26 
The only executive problem during the present 
study was the strict coordination with prisons which 
reduced the sample size in high risk group. Regarding 
the method of sample collection, the possibility of 
generalizing these results about public is limited; 
though considering the dispersion and wide coverage 
of social security insurance, on the other side, high-
risk samples obtained from prison and one of the 
DICs in Tehran, the results of this study might be ap-
plied in health plans. 
In conclusion, HSV-2 infection was associated 
with high risk behaviors such as anal and oral sex, 
condom use during sexual intercourses, smoking and 
drug abuse. Therefore, relatively high prevalence of 
genital Herpes among high risk women necessitates 
regular screening programs. Implementation of geni-
tal Herpes screening has been recommended to begin 
in high-risk groups with inexpensive serological tests, 
especially that the majority of them were in contact 
with various people and the disease could be easily 
spread in the community. Moreover, regarding the 
prevalence rate of 7.1% for IgM antibody in low risk 
women, risk of acute infection in this group should 
not be ignored. Therefore, safe sex education pro-
grams and diagnosis of HSV-2 symptoms should be 
considered in both groups to prevent the disease 
transmission to others in the community. Teaching 
individuals for protective strategies such as condom 
use and avoiding multi-partner sex should be started 
at young ages because age at first sexual contact was 
9 years old in high risk group. In addition, administra-
tion of education programs in just married couples 
based on the assumption that in Iranian population it 
is not usual to have sexual contact before marriage 
may have an effective role in control and prevention 
of HSV-2 infection.  
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